Table of Contents

1 Market Overview
1.1 Hydroxycarbamide Introduction
1.2 Market Analysis by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Market Analysis by Applications
1.3.1 Sickle Cell Disease
1.3.2 Cancer
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol Myers Squibb
2.1.1 Business Overview
2.1.2 Hydroxycarbamide Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Taj Pharma
2.2.1 Business Overview
2.2.2 Hydroxycarbamide Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Taj Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Beijing Jialin Pharma
2.3.1 Business Overview
2.3.2 Hydroxycarbamide Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Qilu Pharmaceutical
2.4.1 Business Overview
2.4.2 Hydroxycarbamide Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva Pharma
2.5.1 Business Overview
2.5.2 Hydroxycarbamide Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Teva Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cipla
2.6.1 Business Overview
2.6.2 Hydroxycarbamide Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Cipla Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Zydus Cadila
2.7.1 Business Overview
2.7.2 Hydroxycarbamide Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Zydus Cadila Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 United Biotech
2.8.1 Business Overview
2.8.2 Hydroxycarbamide Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 United Biotech Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Par Pharma
2.9.1 Business Overview
2.9.2 Hydroxycarbamide Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Par Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Khandelwal Laboratories
2.10.1 Business Overview
2.10.2 Hydroxycarbamide Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Alkem (Cytomed)
2.11.1 Business Overview
2.11.2 Hydroxycarbamide Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Alkem (Cytomed) Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Samarth Pharma
2.12.1 Business Overview
2.12.2 Hydroxycarbamide Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Samarth Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 VHB Life Sciences
2.13.1 Business Overview
2.13.2 Hydroxycarbamide Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 VHB Life Sciences Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hydroxycarbamide Market Competition, by Manufacturer
3.1 Global Hydroxycarbamide Sales and Market Share by Manufacturer
3.2 Global Hydroxycarbamide Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Hydroxycarbamide Manufacturer Market Share
3.3.2 Top 6 Hydroxycarbamide Manufacturer Market Share
3.4 Market Competition Trend
4 Global Hydroxycarbamide Market Analysis by Regions
4.1 Global Hydroxycarbamide Sales, Revenue and Market Share by Regions
4.1.1 Global Hydroxycarbamide Sales by Regions (2012-2017)
4.1.2 Global Hydroxycarbamide Revenue by Regions (2012-2017)
4.2 North America Hydroxycarbamide Sales and Growth (2012-2017)
4.3 Europe Hydroxycarbamide Sales and Growth (2012-2017)
4.4 Asia-Pacific Hydroxycarbamide Sales and Growth (2012-2017)
4.5 South America Hydroxycarbamide Sales and Growth (2012-2017)
4.6 Middle East and Africa Hydroxycarbamide Sales and Growth (2012-2017)
5 North America Hydroxycarbamide by Countries
5.1 North America Hydroxycarbamide Sales, Revenue and Market Share by Countries
5.1.1 North America Hydroxycarbamide Sales by Countries (2012-2017)
5.1.2 North America Hydroxycarbamide Revenue by Countries (2012-2017)
5.2 USA Hydroxycarbamide Sales and Growth (2012-2017)
5.3 Canada Hydroxycarbamide Sales and Growth (2012-2017)
5.4 Mexico Hydroxycarbamide Sales and Growth (2012-2017)
6 Europe Hydroxycarbamide by Countries
6.1 Europe Hydroxycarbamide Sales, Revenue and Market Share by Countries
6.1.1 Europe Hydroxycarbamide Sales by Countries (2012-2017)
6.1.2 Europe Hydroxycarbamide Revenue by Countries (2012-2017)
6.2 Germany Hydroxycarbamide Sales and Growth (2012-2017)
6.3 UK Hydroxycarbamide Sales and Growth (2012-2017)
6.4 France Hydroxycarbamide Sales and Growth (2012-2017)
6.5 Russia Hydroxycarbamide Sales and Growth (2012-2017)
6.6 Italy Hydroxycarbamide Sales and Growth (2012-2017)
7 Asia-Pacific Hydroxycarbamide by Countries
7.1 Asia-Pacific Hydroxycarbamide Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hydroxycarbamide Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Hydroxycarbamide Revenue by Countries (2012-2017)
7.2 China Hydroxycarbamide Sales and Growth (2012-2017)
7.3 Japan Hydroxycarbamide Sales and Growth (2012-2017)
7.4 Korea Hydroxycarbamide Sales and Growth (2012-2017)
7.5 India Hydroxycarbamide Sales and Growth (2012-2017)
7.6 Southeast Asia Hydroxycarbamide Sales and Growth (2012-2017)
8 South America Hydroxycarbamide by Countries
8.1 South America Hydroxycarbamide Sales, Revenue and Market Share by Countries
8.1.1 South America Hydroxycarbamide Sales by Countries (2012-2017)
8.1.2 South America Hydroxycarbamide Revenue by Countries (2012-2017)
8.2 Brazil Hydroxycarbamide Sales and Growth (2012-2017)
8.3 Argentina Hydroxycarbamide Sales and Growth (2012-2017)
8.4 Columbia Hydroxycarbamide Sales and Growth (2012-2017)
9 Middle East and Africa Hydroxycarbamide by Countries
9.1 Middle East and Africa Hydroxycarbamide Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hydroxycarbamide Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Hydroxycarbamide Revenue by Countries (2012-2017)
9.2 Saudi Arabia Hydroxycarbamide Sales and Growth (2012-2017)
9.3 UAE Hydroxycarbamide Sales and Growth (2012-2017)
9.4 Egypt Hydroxycarbamide Sales and Growth (2012-2017)
9.5 Nigeria Hydroxycarbamide Sales and Growth (2012-2017)
9.6 South Africa Hydroxycarbamide Sales and Growth (2012-2017)
10 Global Hydroxycarbamide Market Segment by Type
10.1 Global Hydroxycarbamide Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Hydroxycarbamide Sales and Market Share by Type (2012-2017)
10.1.2 Global Hydroxycarbamide Revenue and Market Share by Type (2012-2017)
10.2 Capsule Sales Growth and Price
10.2.1 Global Capsule Sales Growth (2012-2017)
10.2.2 Global Capsule Price (2012-2017)
10.3 Tablet Sales Growth and Price
10.3.1 Global Tablet Sales Growth (2012-2017)
10.3.2 Global Tablet Price (2012-2017)
11 Global Hydroxycarbamide Market Segment by Application
11.1 Global Hydroxycarbamide Sales Market Share by Application (2012-2017)
11.2 Sickle Cell Disease Sales Growth (2012-2017)
11.3 Cancer Sales Growth (2012-2017)
11.4 Other Sales Growth (2012-2017)
12 Hydroxycarbamide Market Forecast (2017-2022)
12.1 Global Hydroxycarbamide Sales, Revenue and Growth Rate (2017-2022)
12.2 Hydroxycarbamide Market Forecast by Regions (2017-2022)
12.2.1 North America Hydroxycarbamide Market Forecast (2017-2022)
12.2.2 Europe Hydroxycarbamide Market Forecast (2017-2022)
12.2.3 Asia-Pacific Hydroxycarbamide Market Forecast (2017-2022)
12.2.4 South America Hydroxycarbamide Market Forecast (2017-2022)
12.2.5 Middle East and Africa Hydroxycarbamide Market Forecast (2017-2022)
12.3 Hydroxycarbamide Market Forecast by Type (2017-2022)
12.4 Hydroxycarbamide Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source